The neutralization of Th17 cells attenuates liver fibrosis in BDL and CCl4 models through IL-17, IL-1b, TNF-α, IL-2, IL-6, TGF-β serum levels reduction, and downregulation of IL17A and the IL6/STAT3 signaling pathway [113,114]. Here, IL17A is linked to Hepatic fibrosis.